• Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends
Close Search
00
GBAF LogoGBAF Logo
  • Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends
GBAF Logo
  • Top Stories
  • Interviews
  • Business
  • Finance
  • Banking
  • Technology
  • Investing
  • Trading
  • Videos
  • Awards
  • Magazines
  • Headlines
  • Trends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking and Finance Review

Global Banking & Finance Review

Company

    GBAF Logo
    • About Us
    • Profile
    • Wealth
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2025 GBAF Publications Ltd - All Rights Reserved.

    ;
    Editorial & Advertiser disclosure

    Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Top Stories

    Posted By Jessica Weisman-Pitts

    Posted on January 4, 2022

    Featured image for article about Top Stories

    By Renju Jose and Byron Kaye

    SYDNEY (Reuters) – Australian COVID-19 cases soared to a pandemic record on Tuesday as the Omicron variant ripped through most of the country, driving up hospitalisation rates as the once-formidable testing regime buckled under lengthy wait times and stock shortages.

    The country which for a year and half used a system of constant testing, contact tracing and lockdowns to squash most outbreaks, clocked 47,799 new infections, up nearly a third on Monday’s number which was also a record.

    Political leaders have pointed to a largely successful, if slow, vaccination rollout and few deaths, relative to new case numbers – four on Tuesday. But hospitalisations, another closely watched measure, are higher than at any other time in the pandemic: 1,344 in the most populous state New South Wales.

    In Victoria, the second state, the authorities said one in four people showing up for a swab test was returning a positive result. Almost everyone in that state’s intensive care units was unvaccinated, the authorities said. Victoria had 14,020 new cases, nearly double the previous day’s count.

    Other states which had spent much of the pandemic with domestic borders closed and long stretches without a new case, showed similar numbers. A month ago, Queensland reported a day with six new cases; on Tuesday it recorded 5,699.

    Across the country, political leaders have been re-shaping their messaging for a population that is more than 90% vaccinated and a variant that some medical experts say is more transmissable but less virulent than previous strains.

    After nearly two years of campaigning for widespread testing, the authorities want asymptomatic people to bypass government-funded clinics, where high volumes have blown out turnaround times to several days, and take their own rapid antigen tests.

    But that has brought a new pressure point: an explosion in sales of home testing kits, resulting in reports of stockpiling, empty shelves and inflated prices on the few kits which have not yet been sold. Prime Minister Scott Morrison has ruled out subsidising the personal testing kits, citing a heightened role for “personal responsibility”.

    “The problem at the moment is that the lack of (rapid antigen tests) is completely hampering ‘personal responsibility’ and it is a frustration that is a glaring hole in the current management of COVID,” Chris Moy, vice president of the Australian Medical Association, told ABC Radio on Tuesday, using Morrison’s phrase.

    Opposition leader Anthony Albanese, who most polls suggest will defeat Morrison at an election due within months, said that “when it comes to healthcare, and rapid antigen testing, the prime minister has said that you are on your own”.

    The country’s competition regulator said it would set up a team to look into complaints about allegations of price gouging for the at-home rapid antigen tests.

    Despite the spike in infections fuelled by Omicron, dual-dose vaccination levels of nearly 92% in people above 16 have helped Australia to keep the death rate lower than the previous virus outbreaks.

    Authorities do not specify the coronavirus variant that caused the deaths, although New South Wales officials said 74% of patients in the state’s intensive care units since Dec. 16 were infected with the Delta variant.

    The record spike in infections and hospitalisations comes as 2 million more Australians became eligible for their COVID-19 booster shots from Tuesday after authorities shortened the wait time between second and third shots to four months.

    Just over 2.5 million Australians have so far received their booster shot, which health officials hope will keep rates of death and serious illness low.

    Australia crossed half a million coronavirus cases since the pandemic began, with nearly 50% in the last two weeks. Still, its 547,160 cases and 2,270 deaths, from a population of 25 million, are lower than numbers seen in many developed countries.

     

    (Reporting by Renju Jose and Byron Kaye; Editing by Sandra Maler and Michael Perry)

     

    By Renju Jose and Byron Kaye

    SYDNEY (Reuters) – Australian COVID-19 cases soared to a pandemic record on Tuesday as the Omicron variant ripped through most of the country, driving up hospitalisation rates as the once-formidable testing regime buckled under lengthy wait times and stock shortages.

    The country which for a year and half used a system of constant testing, contact tracing and lockdowns to squash most outbreaks, clocked 47,799 new infections, up nearly a third on Monday’s number which was also a record.

    Political leaders have pointed to a largely successful, if slow, vaccination rollout and few deaths, relative to new case numbers – four on Tuesday. But hospitalisations, another closely watched measure, are higher than at any other time in the pandemic: 1,344 in the most populous state New South Wales.

    In Victoria, the second state, the authorities said one in four people showing up for a swab test was returning a positive result. Almost everyone in that state’s intensive care units was unvaccinated, the authorities said. Victoria had 14,020 new cases, nearly double the previous day’s count.

    Other states which had spent much of the pandemic with domestic borders closed and long stretches without a new case, showed similar numbers. A month ago, Queensland reported a day with six new cases; on Tuesday it recorded 5,699.

    Across the country, political leaders have been re-shaping their messaging for a population that is more than 90% vaccinated and a variant that some medical experts say is more transmissable but less virulent than previous strains.

    After nearly two years of campaigning for widespread testing, the authorities want asymptomatic people to bypass government-funded clinics, where high volumes have blown out turnaround times to several days, and take their own rapid antigen tests.

    But that has brought a new pressure point: an explosion in sales of home testing kits, resulting in reports of stockpiling, empty shelves and inflated prices on the few kits which have not yet been sold. Prime Minister Scott Morrison has ruled out subsidising the personal testing kits, citing a heightened role for “personal responsibility”.

    “The problem at the moment is that the lack of (rapid antigen tests) is completely hampering ‘personal responsibility’ and it is a frustration that is a glaring hole in the current management of COVID,” Chris Moy, vice president of the Australian Medical Association, told ABC Radio on Tuesday, using Morrison’s phrase.

    Opposition leader Anthony Albanese, who most polls suggest will defeat Morrison at an election due within months, said that “when it comes to healthcare, and rapid antigen testing, the prime minister has said that you are on your own”.

    The country’s competition regulator said it would set up a team to look into complaints about allegations of price gouging for the at-home rapid antigen tests.

    Despite the spike in infections fuelled by Omicron, dual-dose vaccination levels of nearly 92% in people above 16 have helped Australia to keep the death rate lower than the previous virus outbreaks.

    Authorities do not specify the coronavirus variant that caused the deaths, although New South Wales officials said 74% of patients in the state’s intensive care units since Dec. 16 were infected with the Delta variant.

    The record spike in infections and hospitalisations comes as 2 million more Australians became eligible for their COVID-19 booster shots from Tuesday after authorities shortened the wait time between second and third shots to four months.

    Just over 2.5 million Australians have so far received their booster shot, which health officials hope will keep rates of death and serious illness low.

    Australia crossed half a million coronavirus cases since the pandemic began, with nearly 50% in the last two weeks. Still, its 547,160 cases and 2,270 deaths, from a population of 25 million, are lower than numbers seen in many developed countries.

     

    (Reporting by Renju Jose and Byron Kaye; Editing by Sandra Maler and Michael Perry)

     

    Recommended for you

    • Thumbnail for recommended article

    • Thumbnail for recommended article

    • Thumbnail for recommended article

    Why waste money on news and opinions when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe